Akero Therapeutics akerotx.com


Akero Therapeutics is a Cambridge, MA-based biotechnology company focused on treatment of non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases by restoring metabolic balance. The company is developing AKR-001, a novel, long-acting fibroblast growth factor 21 (FGF21) analogue, which was exclusively licensed from Amgen.

Akero Therapeutics is a Cambridge, MA-based biotechnology company focused on treatment of non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases by restoring metabolic balance. The company is developing AKR-001, a novel, long-actin...Show all

Company (Alive / Active)

Phone:

Fax:

400 Technology Square
10th Floor
Cambridge, 0213
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Akero Therapeutics $65M Jun 25, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Akero Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)